Associate Professor
Cancer Institute, University College London, London, UK
London, England, United Kingdom
Dr Paul Batty, is an Associate Professor in Haemophilia at University College London and an Honorary Consultant in Haemostasis and Thrombosis at the Katharine Dormandy Haemophilia and Thrombosis Centre (Royal Free Hospital, London, UK).
He has active research interests in inhibitor immunology, gene therapy and novel therapies for the management of inherited bleeding disorders. Prior to starting at UCL, he completed a three-year post-doctoral fellowship in Dr David Lillicrap’s group, investigating the early and long-term fate of Adeno-associated viral gene therapy in the haemophilia dog model. The aim of these ongoing studies is to provide translational information on safety and efficacy of adeno-associated viral gene therapy. He has previously completed a PhD in Immunobiology, under the supervision of Dr. Dan Hart, investigating factors surrounding FVIII immunogenicity, with an aim at improving detection and characterisation of inhibitors.
He has published a number of articles on gene therapy, inhibitor testing, acquired haemophilia and usage of factor concentrates in the management of the inherited bleeding disorders. He is active in promotion of research and training in haemostasis and thrombosis at undergraduate and postgraduate levels.
OC 02.6 - Gene therapy - Clinical and pre-clinical
Saturday, June 22, 2024
13:00 – 14:15 ICT
Saturday, June 22, 2024
13:00 – 13:15 ICT
Sunday, June 23, 2024
13:45 – 14:45 ICT
Sunday, June 23, 2024
13:45 – 14:45 ICT
Monday, June 24, 2024
14:45 – 15:00 ICT
SSC 018.6 - Session Welcome (Part 2 Introduction)
Monday, June 24, 2024
17:25 ICT
SSC 018.9 - The need for a protocol on liver biopsies
Monday, June 24, 2024
17:45 – 17:55 ICT
OC 57.6 - Methods for laboratory monitoring of hemostatic agents
Tuesday, June 25, 2024
09:30 – 10:45 ICT
Tuesday, June 25, 2024
13:45 – 14:45 ICT
PB1190 - Factor VIII inhibitors exhibit either type I or type II kinetics in acquired haemophilia A
Tuesday, June 25, 2024
13:45 – 14:45 ICT